NO173991C - Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,2,5-ditiazocin-derivater - Google Patents

Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,2,5-ditiazocin-derivater

Info

Publication number
NO173991C
NO173991C NO893249A NO893249A NO173991C NO 173991 C NO173991 C NO 173991C NO 893249 A NO893249 A NO 893249A NO 893249 A NO893249 A NO 893249A NO 173991 C NO173991 C NO 173991C
Authority
NO
Norway
Prior art keywords
dithiazocin
derivatives
preparation
therapeutically active
analogous procedures
Prior art date
Application number
NO893249A
Other languages
English (en)
Norwegian (no)
Other versions
NO173991B (no
NO893249L (no
NO893249D0 (no
Inventor
Takakazu Morita
Shiro Mita
Tadashi Iso
Youichi Kawashima
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of NO893249D0 publication Critical patent/NO893249D0/no
Publication of NO893249L publication Critical patent/NO893249L/no
Publication of NO173991B publication Critical patent/NO173991B/no
Publication of NO173991C publication Critical patent/NO173991C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/18—Eight-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/06—Seven-membered rings having the hetero atoms in positions 1 and 4 not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/38—Eight-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO893249A 1988-08-13 1989-08-11 Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,2,5-ditiazocin-derivater NO173991C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20211188 1988-08-13

Publications (4)

Publication Number Publication Date
NO893249D0 NO893249D0 (no) 1989-08-11
NO893249L NO893249L (no) 1990-02-14
NO173991B NO173991B (no) 1993-11-22
NO173991C true NO173991C (no) 1994-03-02

Family

ID=16452145

Family Applications (1)

Application Number Title Priority Date Filing Date
NO893249A NO173991C (no) 1988-08-13 1989-08-11 Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,2,5-ditiazocin-derivater

Country Status (12)

Country Link
US (3) US5041435A (ko)
EP (1) EP0356006B1 (ko)
KR (1) KR960005953B1 (ko)
CN (1) CN1020726C (ko)
AT (1) ATE102195T1 (ko)
AU (1) AU618113B2 (ko)
CA (1) CA1335285C (ko)
DE (1) DE68913389T2 (ko)
DK (1) DK396989A (ko)
ES (1) ES2052009T3 (ko)
FI (1) FI92693C (ko)
NO (1) NO173991C (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5041435A (en) * 1988-08-13 1991-08-20 Santen Pharmaceutical Co., Ltd. Cyclic sulfur-containing compounds
US5686450A (en) * 1995-06-07 1997-11-11 Alcon Laboratories, Inc. Use of N,N'-bis(mercaptoacetyl) hydrazine derivatives as anticataract agents
US5576278A (en) * 1995-06-07 1996-11-19 Alcon Laboratories, Inc. Stable liquid enzyme compositions and methods of use
US7204988B2 (en) 2003-06-11 2007-04-17 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
FR2876576B1 (fr) * 2004-10-14 2006-12-08 Oreal Composition de teinture comprenant un colorant disulfure particulier et procede de coloration des fibres keratiniques humaines a partir de ce colorant
US20100028439A1 (en) * 2005-05-23 2010-02-04 Elan Pharma International Limited Nanoparticulate stabilized anti-hypertensive compositions
RU2467002C1 (ru) * 2011-05-30 2012-11-20 Учреждение Российской Академии Наук Институт Нефтехимии И Катализа Ран СПОСОБ ПОЛУЧЕНИЯ 3-(o-,м-,п-НИТРОФЕНИЛ)-ТЕТРАГИДРО-2H,6H-1,5,3-ДИТИАЗОЦИНОВ
RU2467000C1 (ru) * 2011-05-30 2012-11-20 Учреждение Российской Академии Наук Институт Нефтехимии И Катализа Ран Способ получения 3-арил-тетрагидро-2н,6н-1,5,3-дитиазоцинов
US20210000727A1 (en) * 2017-12-21 2021-01-07 L'oreal Dithiazocane compounds for the cosmetic use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5756454A (en) * 1980-09-20 1982-04-05 Santen Pharmaceut Co Ltd Disulfide type cysteine derivative
SU1435151A3 (ru) * 1984-04-10 1988-10-30 Санкио Компани Лимитед (Фирма) Способ получени производных пергидротиазепина или их кислотно-аддитивных фармацевтически приемлемых солей
JPH0643390B2 (ja) * 1986-04-08 1994-06-08 久光製薬株式会社 アザシクロアルカン誘導体
US5041435A (en) * 1988-08-13 1991-08-20 Santen Pharmaceutical Co., Ltd. Cyclic sulfur-containing compounds

Also Published As

Publication number Publication date
FI893682A0 (fi) 1989-08-03
AU618113B2 (en) 1991-12-12
DE68913389T2 (de) 1994-06-23
FI92693B (fi) 1994-09-15
US5041435A (en) 1991-08-20
DK396989D0 (da) 1989-08-11
US5082836A (en) 1992-01-21
NO173991B (no) 1993-11-22
NO893249L (no) 1990-02-14
FI893682A (fi) 1990-02-14
ATE102195T1 (de) 1994-03-15
CN1040368A (zh) 1990-03-14
NO893249D0 (no) 1989-08-11
EP0356006B1 (en) 1994-03-02
DE68913389D1 (de) 1994-04-07
KR960005953B1 (ko) 1996-05-06
ES2052009T3 (es) 1994-07-01
AU3895689A (en) 1990-02-15
EP0356006A1 (en) 1990-02-28
CN1020726C (zh) 1993-05-19
US5128467A (en) 1992-07-07
FI92693C (fi) 1994-12-27
DK396989A (da) 1990-02-14
CA1335285C (en) 1995-04-18
KR900003142A (ko) 1990-03-23

Similar Documents

Publication Publication Date Title
ATE260255T1 (de) 5-oxo-pyrrolidine-2-carbonsäure- hydroxamidderivate
OA09334A (fr) "Dérivés d'acides aminés".
NO882036D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske ketoner.
DK586085D0 (da) Piperazinderivater og fremgangsmaade til deres fremstilling
DE68914292D1 (de) Zusammensetzung zur Behandlung von ischämischen Störungen in Organen.
NO882238D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive cykliske peptider.
NO882239L (no) Fremgangsmaate for fremstilling av terapeutisk aktive cykliske peptider.
NO173444C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 4-(4'- fluorfenyl-)-tienopyridin-derivater
NO173991C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,2,5-ditiazocin-derivater
FI903571A0 (fi) Menetelmä farmaseuttisesti aktiivisten peptidien valmistamiseksi
DK183789A (da) 2-alkyl-3-benzoylbenzofuraner og laegemidler indeholdende disse
DE69419954D1 (de) Arzneimittel zur Behandlung von Hauterkrankungen
ATE84303T1 (de) Cysteinderivate.
NO164474C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heksahydropyrrolo(2,1-a)isokinolin-derivater.
DE3880564D1 (de) Arzneimittel zur behandlung von herzinsuffizienz.
DK0551844T3 (da) Svovlholdige galdesyrederivater
ATE186912T1 (de) Carbamoylpyrrolidon-derivate zur behandlung von depressionen und cerebrovasculären störungen
ATE95697T1 (de) Uricosuretische zusammensetzung.
DE69908855D1 (de) 9a, 11b-dehydro Derivative von 9-oxime-3-keto-6-0-methylerythromycin